IBO logo

Impact BioMedical (IBO)

Profile

Full Name

Impact BioMedical Inc.

Ticker Symbol

IBO

Exchange

NYSE American

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

Indexes

Not included

Website

http://www.impactbiomedinc.com

Employees

2

Key Details

Price

$0.40(-7.78%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$2.30(-3185.71% YoY)

PE ratio

-

Next earnings date

May 9, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$0.40
IBO price is $0.40

30-Day Relative Volume

0.03
IBO 30-day relative volume is 0.03

Price Performance

Price Most recent change

-7.78%
IBO price was down -7.78% on Apr 17, 2025

Price YTD change

-72.21%
IBO price is down -72.21% since January 1st

Price 1-year change

-
IBO price 1-year change is unknown

Price 3-year change

-
IBO price 3-year change is unknown

Price Range

Price All-time high

$6.17
IBO price is currently -93.47% below its historical high of $6.17

Price 3-year low

$0.37
IBO price is currently +8.92% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$4.87M
IBO market capitalization is $4.87 million

Market cap 3-year change

-
IBO market capitalization 3-year change is unknown

Market cap All-time high

$59.94M
IBO market capitalization is currently -91.88% below its historical high of $59.94 million

Market cap sector rank

13.17%
IBO market capitalization is higher than 13.17% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

-
IBO shares outstanding 1-year change is unknown

Shares Outstanding 3-Year Change

-
IBO shares outstanding 3-year change is unknown

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

-2.41
IBO beta is -2.41

200-day SMA

$1.83
IBO price is currently -77.93% below its 200-day simple moving average

50-day SMA

$1.44
IBO price is currently -71.97% below its 50-day simple moving average

RSI

40.55
IBO 14-day relative strength index is 40.55

Volume

0.03
IBO 30-day relative volume is 0.03

ATR

$0.38
IBO average true range is $0.38

10-day Historical Volatility

602.09%
IBO 10-day historical volatility is 602.09%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

-
IBO annual revenue value is unknown

Revenue Analysts estimate

-
IBO annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

-
IBO annual revenue 1-year change is unknown

Revenue Sector rank

-
IBO annual revenue is unknown

EPS

EPS

-$2.30
IBO annual earnings per share is -$2.30

EPS Analysts estimate

-
IBO annual earnings per share consensus analysts' forecast is unknown

EPS 1-year change

-3185.71%
IBO annual earnings per share is down -3185.71% year-on-year

EPS Sector rank

36.12%
IBO annual earnings per share is higher than 36.12% of companies in Healthcare sector

Profit

Gross profit

-
IBO annual gross profit value is unknown

Gross margin

-
IBO annual gross profit margin value is unknown

Operating profit

-$3.40M
IBO annual operating income is -$3.40 million

Operating margin

-
IBO annual operating profit margin value is unknown

Net income

-$24.71M
IBO annual net profit is -$24.71 million

Net margin

-
IBO annual net profit margin value is unknown

Expenses

Total expenses

$3.40M
IBO annual total expenses is $3.40 million

Operating expenses

$3.40M
IBO annual total operating expenses is $3.40 million

Cost of goods sold

-
IBO annual cost of goods sold value is unknown

Selling, general & administrative expenses

$1.83M
IBO annual SGA is $1.83 million

Depreciation and amortization

$1.12M
IBO annual depreciation & amortization is $1.12 million

Interest expense

$1.06M
IBO annual interest expense is $1.06 million

Income tax

$33.00K
IBO annual income tax is $33.00 thousand

EBIT & EBITDA

EBIT

-$23.67M
IBO annual earnings before interest & taxes is -$23.67 million

EBITDA

-$22.55M
IBO annual EBITDA is -$22.55 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$20.29M
IBO annual total assets is $20.29 million

Non current assets

$17.84M
IBO annual long term assets is $17.84 million

Current assets

$2.45M
IBO annual total current assets is $2.45 million

Cash and cash equivalents

$2.00M
IBO annual cash & cash equivalents is $2.00 million

Accounts receivable

-
IBO annual accounts receivable value is unknown

Inventory

-
IBO annual inventory value is unknown

Liabilities

Total liabilities

$13.05M
IBO annual total liabilities is $13.05 million

Long term liabilities

$3.27M
IBO annual total long term liabilities is $3.27 million

Current liabilities

$9.79M
IBO annual total current liabilities is $9.79 million

Accounts payable

$713.00K
IBO annual accounts payable is $713.00 thousand

Debt

Total debt

$8.88M
IBO annual total debt is $8.88 million

Total debt 1-year change

-26.47%
IBO annual total debt is down -26.47% year-on-year

Long term debt

-
IBO annual long term debt value is unknown

Short term debt

$8.88M
IBO annual short term debt is $8.88 million

Equity & Capital

Shareholders equity

$4.26M
IBO annual stockholders equity is $4.26 million

Book value

$4.20M
IBO annual book value is $4.20 million

Retained earnings

-$37.67M
IBO annual retained earnings is -$37.67 million

Working capital

-$7.34M
IBO annual working capital is -$7.34 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$3.92M
IBO annual cash flow from operations is -$3.92 million

Cash from operations 1-year change

-37.46%
IBO annual cash flow from operations is down -37.46% year-on-year

Cash from investing

$2000.00
IBO annual cash flow from investing activities is $2000.00

Cash from investing 1-year change

+113.33%
IBO annual cash flow from investing activities is up +113.33% year-on-year

Cash from financing

$5.92M
IBO annual cash flow from financing activities is $5.92 million

Cash from financing 1-year change

+106.46%
IBO annual cash flow from financing activities is up +106.46% year-on-year

CAPEX

CAPEX

-
IBO annual capital expenditures value is unknown

CAPEX 1-year change

-
IBO annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$3.92M
IBO annual free cash flow is -$3.92 million

Free cash flow 1-year change

-36.6%
IBO annual free cash flow is down -36.6% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
IBO annual gross profit margin value is unknown

Operating margin

-
IBO annual operating profit margin value is unknown

Net margin

-
IBO annual net profit margin value is unknown

ROA & ROE

ROA

-121.77%
IBO annual return on assets is -121.77%

ROE

-580.14%
IBO annual return on equity is -580.14%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
IBO price to earnings ratio value is unknown

PE ratio Sector rank

-
IBO price to earnings ratio is unknown

PB Ratio

PB ratio

1.16
IBO price to book ratio is 1.16

PB ratio Sector rank

47.73%
IBO price to book ratio is higher than 47.73% of companies in Healthcare sector

PS Ratio

PS ratio

-
IBO price to sales ratio value is unknown

PS ratio Sector rank

-
IBO price to sales ratio is unknown

Enterprise value

Enterprise value

$11.75M
IBO enterprise value is $11.75 million

Enterprise value Sector rank

26.45%
IBO enterprise value is higher than 26.45% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-0.52
IBO EV/EBITDA is -0.52

EV/EBITDA Sector rank

51%
IBO EV/EBITDA is higher than 51% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

0.25
IBO annual current ratio is 0.25

Quick ratio

-
IBO annual quick ratio value is unknown

Leverage

Debt to equity

2.08
IBO annual debt to equity ratio is 2.08

Interest coverage ratio

-22.23
IBO annual interest coverage ratio is -22.23

Risk & Stability

Piotroski F-Score

-
IBO piotroski f-score value is unknown

Altman Z-Score

-
IBO altman z-score value is unknown

Analyst ratings

Recent major analysts updates

No data about analysts updates

Institutional Ownership

Similar stocks

CPHI logo
China Pharma Holdings (CPHI)
Klotho Neurosciences (KLTO)
SPRB logo
Spruce Biosciences (SPRB)
SILO logo
Silo Pharma (SILO)
IMCC logo
IM Cannabis (IMCC)
CELZ logo
Creative Medical Technology Holdings (CELZ)
GMDA logo
Gamida Cell (GMDA)
NSTG logo
NanoString Technologies (NSTG)
GTBP logo
GT Biopharma (GTBP)
  • What is the ticker symbol for Impact BioMedical?
  • Does Impact BioMedical pay dividends?
  • What sector is Impact BioMedical in?
  • What industry is Impact BioMedical in?
  • What country is Impact BioMedical based in?
  • Is Impact BioMedical in the S&P 500?
  • Is Impact BioMedical in the NASDAQ 100?
  • Is Impact BioMedical in the Dow Jones?
  • When was Impact BioMedical's last earnings report?
  • When does Impact BioMedical report earnings?

What is the ticker symbol for Impact BioMedical?

The ticker symbol for Impact BioMedical is NYSE American:IBO

Does Impact BioMedical pay dividends?

No, Impact BioMedical does not pay dividends

What sector is Impact BioMedical in?

Impact BioMedical is in the Healthcare sector

What industry is Impact BioMedical in?

Impact BioMedical is in the Biotechnology industry

What country is Impact BioMedical based in?

Impact BioMedical is headquartered in United States

Is Impact BioMedical in the S&P 500?

No, Impact BioMedical is not included in the S&P 500 index

Is Impact BioMedical in the NASDAQ 100?

No, Impact BioMedical is not included in the NASDAQ 100 index

Is Impact BioMedical in the Dow Jones?

No, Impact BioMedical is not included in the Dow Jones index

When was Impact BioMedical's last earnings report?

Impact BioMedical's most recent earnings report was on Nov 12, 2024

When does Impact BioMedical report earnings?

The next expected earnings date for Impact BioMedical is May 9, 2025
On this page